Cell-surface thioredoxin-1: Possible involvement in thiol-mediated leukocyte-endothelial cell interaction through lipid rafts

Antioxidants and Redox Signaling

Volumn 9, Issue 9, 2007, Pages 1427-1437

  Hara, Tomijiro ^a,d   Kondo, Norihiko ^c   Nakamura, Hajime ^b   Okuyama, Hiroaki ^b   Mitsui, Akira ^a   Hoshino, Yuma ^b   Yodoi, Junji ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^d Redox Bioscience Inc   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; CYSTEINE; CYTOKINE; DISULFIDE; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; MUTANT PROTEIN; RECOMBINANT PROTEIN; THIOL; THIOREDOXIN; THIOREDOXIN 1; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CELL INTERACTION; CELL PROTECTION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKOCYTE; LIPID RAFT; MONONUCLEAR CELL; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; T LYMPHOCYTE ACTIVATION; VIRUS TRANSFORMATION; WILD TYPE;

CELL LINE, TRANSFORMED; ENDOTHELIUM, VASCULAR; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; JURKAT CELLS; LEUKOCYTES; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; RECOMBINANT PROTEINS; THIOREDOXIN;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 34547902170     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1661     Document Type: Article

References (39)

1. Bernhagen J, Calandra T, and Bucala R. The emerging role of MIF in septic shock and infection. Biotherapy 8: 123-127, 1994.
2. Bertini R, Howard OM, Dong HF, Oppenheim JJ, Bizzarri C, Sergi R, Caselli G, Pagliei S, Romines B, Wilshire JA, Mengozzi M, Nakamura H, Yodoi J, Pekkari K, Gurunath R, Holmgren A, Herzenberg LA, and Ghezzi P. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J Exp Med 189: 1783-1789, 1999.
3. Chae HZ, Robison K, Poole LB, Church G, Storz G, and Rhee SG. Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific anti-oxidant define a large family of antioxidant enzymes. Proc Natl Acad Sci U S A 91: 7017-7021, 1994.
4. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, and Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci U S A 94: 3633-3638, 1997.
5. Hirota K, Matsui M, Murata M, Takashima Y, Cheng F S, Itoh T, Fukuda K, and Yodoi J. Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-kappaB, AP-1, and CREB activation in HEK293 cells, Biochem Biophys Res Commun 274: 177-182, 2000.
6. Hoshino T, Nakamura H, Okamoto M, Kato S, Araya S, Nomiyama K, Oizumi K, Young H A, Aizawa H, and Yodoi J. Redox-active protein thioredoxin prevents proinflammatory cytokine- or bleomycin-induced lung injury. Am J Respir Crit Care Med 168: 1075-1083, 2003.
7. Janes PW, Ley SC, and Magee AI. Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor. J Cell Biol 147: 447-461, 1999.
8. Kondo N, Ishii Y, Kwon Y W, Tanito M, Horita H, Nishinaka Y, Nakamura H, and Yodoi J. Redox-sensing release of human thioredoxin from T lymphocytes with negative feedback loops. J Immunol 172: 442-448, 2004.
9. Kosugi A, Sakakura J, Yasuda K, Ogata M, and Hamaoka T. Involvement of SHP-1 tyrosine phosphatase in TCR-mediated signaling pathways in lipid rafts. Immunity 14: 669-680, 2001.
10. Ley K. Arrest chemokines. Microcirculation 10: 289-295, 2003.
11. Lowe JB. Glycan-dependent leukocyte adhesion and recruitment in inflammation. Curr Opin Cell Biol 15: 531-538, 2003.
12. Lowin-Kropf B, Shapiro VS, and Weiss A. Cytoskeletal polarization of T cells is regulated by an immunoreceptor tyrosine-based activation motif-dependent mechanism. J Cell Biol 140: 861-871, 1998.
13. Martin H and Dean M. Identification of a thioredoxin-related protein associated with plasma membranes. Biochem Biophys Res Commun 175: 123-128, 1991.
14. Matthias LJ, Yam PT, Jiang XM, Vandegraaff N, Li P, Poumbourios P, Donoghue N, and Hogg PJ. Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1. Nat Immunol 3: 727-732, 2002.
15. Miller LA, Usachenko J, McDonald RJ, and Hyde DM. Trafficking of neutrophils across airway epithelium is dependent upon both thioredoxin- and pertussis toxin-sensitive signaling mechanisms. J Leukoc Biol 68: 201-208, 2000.
16. Mitsui A, Hirakawa T, and Yodoi J. Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor/human thioredoxin. Biochem Biophys Res Commun 186: 1220-1226, 1992.
17. Motohashi K, Kondoh A, Stumpp MT, and Hisabori T. Comprehensive survey of proteins targeted by chloroplast thioredoxin. Proc Natl Acad Sci U S A 98: 11224-11229, 2001.
18. Nakamura H, Herzenberg LA, Bai J, Araya S, Kondo N, Nishinaka Y, and Yodoi J. Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis. Proc Natl Acad Sci U S A 98: 15143-15148, 2001.
19. Nakamura H, Tamura S, Watanabe I, Iwasaki T, and Yodoi J. Enhanced resistancy of thioredoxin-transgenic mice against influenza virus-induced pneumonia. Immunol Lett 82: 165-170, 2002.
20. Okubo K, Kosaka S, Isowa N, Hirata T, Hitomi S, Yodoi J, Nakano M, and Wada H. Amelioration of ischemia-reperfusion injury by human thioredoxin in rabbit lung. J Thorac Cardiovasc Surg 113: 1-9, 1997.
21. Oslund KL, Miller LA, Usachenko JL, Tyler N K, Wu R, and Hyde DM. Oxidant-injured airway epithelial cells upregulate thioredoxin but do not produce interleukin-8. Am J Respir Cell Mol Biol 30: 597-604, 2004.
22. Potolicchio I, Santambrogio L, and Strominger JL. Molecular interaction and enzymatic activity of macrophage migration inhibitory factor with immunorelevant peptides. J Biol Chem 278: 30889-30895, 2003.
23. Roy S, Sen CK, and Packer L. Determination of cell-cell adhesion in response to oxidants and antioxidants. Methods Enzymol 300: 395-401, 1999.
24. Rubartelli A, Bajetto A, Allavena G, Wollman E, and Sitia R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J Biol Chem 267: 24161-24164, 1992.
25. Sachi Y, Hirota K, Masutani H, Toda K, Okamoto T, Takigawa M, and Yodoi J. Induction of ADF/TRX by oxidative stress in keratinocytes and lymphoid cells. Immunol Lett 44: 189-193, 1995.
26. Sahaf B, Heydari K, and Herzenberg L A. Lymphocyte surface thiol levels. Proc Natl Acad Sci U S A 100: 4001-4005, 2003.
27. Sahaf B, Heydari K, and Herzenberg L A. The extracellular microenvironment plays a key role in regulating the redox status of cell surface proteins in HIV-infected subjects. Arch Biochem Biophys 434: 26-32, 2005.
28. Schwartz EA, Reaven E, Topper JN, and Tsao PS. Transforming growth factor-beta receptors localize to caveolae and regulate endothelial nitric oxide synthase in normal human endothelial cells. Biochem J 390: 199-206, 2005.
29. Sen CK and Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 10: 709-720, 1996.
30. Sprenger RR, Fontijn RD, van Marie J, Pannekoek H, and Horrevoets AJ. Spatial segregation of transport and signalling functions between human endothelial caveolae and lipid raft proteomes. Biochem J 400: 401-410, 2006.
31. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314, 1994.
32. Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matsui H, Hamuro J, Brown N, Arai K, Yokota T, Wakasugi H, and . ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J 13: 2244, 1994.
33. Takagi Y, Mitsui A, Nishiyama A, Nozaki K, Sono H, Gon Y, Hashimoto N, and Yodoi J. Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc Natl Acad Sci U S A 96: 4131-4136, 1999.
34. Tanimura N, Nagafuku M, Minaki Y, Umeda Y, Hayashi F, Sakakura J, Kato A, Liddicoat D R, Ogata M, Hamaoka T, and Kosugi A. Dynamic changes in the mobility of LAT in aggregated lipid rafts upon T cell activation. J Cell Biol 160: 125-135, 2003.
35. Ueda S, Nakamura T, Yamada A, Teratani A, Matsui N, Furukawa S, Hoshino Y, Narita M, Yodoi J, and Nakamura H. Recombinant human thioredoxin suppresses lipopolysaccharide-induced bronchoalveolar neutrophil infiltration in rat. Life Sci 79: 1170-1177, 2006.
36. Verdoucq L, Vignols F, Jacquot JP, Chartier Y, and Meyer Y. In vivo characterization of a thioredoxin h target protein defines a new peroxiredoxin family. J Biol Chem 274: 19714-19722, 1999.
37. Waeber G, Calandra T, Bonny C, and Bucala R. A role for the endocrine and pro-inflammatory mediator MIF in the control of insulin secretion during stress. Diabetes Metab Res Rev 15: 47-54, 1999.
38. Wollman EE, Kahan A, and Fradelizi D. Detection of membrane associated thioredoxin on human cell lines. Biochem Biophys Res Commun 230: 602-606, 1997.
39. Yagi K, Wada H, Fukuse T, Hirata T, Liu CJ, Bando T, Kosaka S, Okubo K, Gro T, Yokomise H et al. Inhibition of reperfusion injury by rADF/human thioredoxin in canine lung transplantation. Transplant Proc 26: 878-879, 1994.